Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 162
Infectious Diseases Drugs 123
Genomics 101
Liver and Kidney Disorders Drugs 68
Immune Disorders Drugs 61
Pharmaceuticals 51
Drug Discovery 48
Cardiovascular Drugs 44
Biopharmaceuticals 42
Biotechnology 41
Leukemia Drugs 36
HIV/AIDS Drugs 36
Lymphoma Drugs 29
Allergy and Immunology 28
Clinical Trials 28
Musculoskeletal Disorders Drugs 27
Enzymes 26
Respiratory Drugs 26
Oncology 22
Pulmonary Medicine 21
Central Nervous System Drugs 20
Infusions and Injectables 19
Drug Delivery 19
Pharmaceutical Manufacturing 17
Gastrointestinal Drugs 13
Infectious Disease Testing 12
Vaccines 12
Endocrine and Metabolic Disorders Drugs 11
Healthcare Services 10
Diagnostics 10
Hematology 10
Hematological Drugs 10
Sexual and Reproductive Health Drugs 10
Antibiotics 9
Pharmaceutical Intermediates 8
Therapeutic Area 8
Optical Disorders Drugs 8
Breast Cancer Drugs 8
Stem Cells 8
Drugs by Therapeutic Area 6
Women's Health 6
Lung Cancer Drugs 6
Company Reports 5
Hepatology 5
Colon Cancer Drugs 5
Analgesics 5
Needles and Syringes 5
Nanomedicine 5
Cervical Cancer Drugs 4
Anesthetic Drugs 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Liver Cancer Drugs 3
Generic Drugs 3
Bladder Cancer Drugs 3
Dental 3
Optical 3
Medical Devices 3
Over the Counter (OTC) Drugs 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
E-Healthcare 2
Pharmacoeconomics 2
Prostate Cancer Drugs 2
Ovarian Cancer Drugs 2
Brain Cancer Drugs 2
In Vitro Diagnostics 2
Cancer Vaccines 2
Kidney Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Pediatrics 2
Gastroenterology 2
Cardiology 2
Urological Disorders Drugs 2
Animal Pharmaceuticals 1
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Proteomics 1
Cardiovascular Devices 1
Home Testing and Home Healthcare 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Blood Banking 1
Hospital Management 1
Surgical Procedures 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



282 reviews

1,019 Results (Page 30 of 51)
- Relevance
  Sort by

Candidiasis Therapeutics Market - Global Strategic Business Report

 Report
April 2026
474 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Cutaneous and Systemic Leishmaniasis Market - Global Strategic Business Report

 Report
April 2026
473 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Cytomegalovirus (CMV) Treatment - Global Strategic Business Report

 Report
April 2026
384 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

West Nile Virus - Global Strategic Business Report

 Report
April 2026
169 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Multiple Myeloma Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

 Report
May 2025
200 Pages
Global

From

€2229EUR$2,490USD£1,947GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Candidiasis Drugs - Global Strategic Business Report

 Report
April 2026
250 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Oncologists Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4019EUR$4,490USD£3,511GBP

Coronary Artery Disease Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4019EUR$4,490USD£3,511GBP

Autoimmune Drugs - Global Strategic Business Report

 Report
April 2026
287 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Anti-Inflammatory Drugs - Global Strategic Business Report

 Report
April 2026
488 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Chronic Lymphocytic Leukemia Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4019EUR$4,490USD£3,511GBP

Specialty Pharmaceuticals - Global Strategic Business Report

 Report
April 2026
291 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Prescription Drugs - Global Strategic Business Report

 Report
April 2026
269 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Cystitis- Pipeline Insight, 2025

 Clinical Trials
April 2025
80 Pages
Global

From

€1343EUR$1,500USD£1,173GBP

Nanomedicine Market - Forecasts from 2023 to 2028

 Report
September 2023
146 Pages
Global

From

€3983EUR$4,450USD£3,479GBP

Immunotherapy Drugs Market Size, Share & Trends by Type (mAb, Checkpoint Inhibitor, Interferon, Cancer Vaccine), Application (Cancer, Autoimmune, Inflammatory, Hematology, Neurology), Route of Administration (Intravenous, Subcutaneous), End User - Forecast to 2029

 Report
July 2024
335 Pages
Global

From

€4431EUR$4,950USD£3,870GBP

Mantle Cell Lymphoma Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

 Report
August 2022
117 Pages
Global

From

€4028EUR$4,500USD£3,519GBP

Sterile Injectable Drugs - Global Strategic Business Report

 Report
April 2026
194 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions

 Report
March 2025
211 Pages
Global

From

€4162EUR$4,650USD£3,636GBP

Antiviral Drugs Market Report 2022-2032

 Report
November 2022
285 Pages
Global

From

€4680EUR$5,412USD£3,950GBP

1,019 Results (Page 30 of 51)
- 1
- 28
- 29
- 30
- 31
- 32

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.